Schrodinger, Inc.(SDGR)内部人交易:高管与董事近期交易
过去 18 个月,共有 19 位内部人为 Schrodinger, Inc.(SDGR)报告了 70 笔 Form 4 交易(最近一笔 2026-11-12)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-12 | Abel Robert Lorne | EVP, Chief Scientific Officer, Platform | 买入 | 21,927 | $372,759 |
| 2026-11-12 | Davie Paul Jonathan | EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing | 买入 | 18,400 | $0 |
| 2026-11-12 | Abel Robert Lorne | EVP, Chief Scientific Officer, Platform | 卖出 | 21,927 | $745,518 |
| 2026-11-12 | Abel Robert Lorne | EVP, Chief Scientific Officer, Platform | 卖出 | 1,678 | $57,052 |
| 2026-11-10 | Tran Yvonne | EVP, CLO & CPO | 买入 | 32,000 | $544,000 |
| 2026-11-10 | Tran Yvonne | EVP, CLO & CPO | 卖出 | 400 | $11,989 |
| 2026-11-10 | Tran Yvonne | EVP, CLO & CPO | 卖出 | 2,100 | $66,051 |
| 2026-11-10 | Tran Yvonne | EVP, CLO & CPO | 卖出 | 7,901 | $257,897 |
| 2026-11-10 | Tran Yvonne | EVP, CLO & CPO | 卖出 | 21,599 | $715,186 |
| 2026-09-21 | Akinsanya Karen | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 买入 | 31,599 | $137,140 |
| 2026-09-21 | Akinsanya Karen | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 卖出 | 10,000 | $280,000 |
| 2026-09-21 | Akinsanya Karen | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 卖出 | 21,599 | $647,970 |
| 2026-07-17 | Jain Rachit | EVP & CFO | 卖出 | 875 | $13,650 |
| 2026-06-29 | Friesner Richard | 董事 | 卖出 | 679,373 | $0 |
| 2026-06-29 | Friesner Richard | 董事 | 买入 | 679,373 | $0 |
| 2026-06-23 | GINSBERG GARY L | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | Lynton Michael | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | OBEROI ARUN | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | Chodakewitz Jeffrey | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | Thornberry Nancy | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | Friesner Richard | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | Kapeller-Libermann Rosana | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | Sender Gary | 董事 | 买入 | 8,141 | $0 |
| 2026-06-23 | van Kralingen Bridget A | 董事 | 买入 | 8,141 | $0 |
| 2026-04-17 | Jain Rachit | EVP & CFO | 卖出 | 844 | $10,761 |
来源:SEC Form 4 申报文件 · 截至 2026-11-12